Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Oddity Tech: Recovery Visible, But Growth Isn't Guaranteed Yet
These Analysts Boost Their Forecasts On Oddity Tech After Upbeat Q3 Results
Oddity Tech (ODD) Q3 Earnings and Revenues Beat Estimates
Oddity Tech Ltd. (ODD) Q3 2026 Earnings Call Transcript
What ODDITY Tech (ODD) Said on Its Q3 Earnings Call
ODDITY Tech Reports Third Quarter 2026 Results Ahead of Plan, Raises Full Year Net Revenue And Adjusted EBITDA Outlook
New Strong Buy Stocks for November 4th
New Strong Buy Stocks for October 29th
ODDITY to Announce Third Quarter 2026 Financial Results on November 11, 2026
Baillie Gifford Trims ODDITY Tech Ltd (ODD) Stake -- Shares Look 55% Undervalued on GF Value
Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate NDA Resubmission and PDUFA Date of March 25, 2027
ImmunoForge to Showcase Proprietary Platform Technologies and Next-Generation Oncology & Phase 2 Clinical Pipelines at BIO-Europe 2026
Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate NDA Resubmission and PDUFA Date of March 25, 2027
Oddity Tech (ODD) Upgraded to Strong Buy: Here's What You Should Know
New Strong Buy Stocks for October 15th
Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Opamtistomig (LBL-024) Granted Orphan Drug Designation in Japan, Further Expanding Global Regulatory Recognition
ODDITY Tech Ltd (ODD) Shares Fall 5.1% -- What GF Score of 71 Tells Investors
Earnings Estimates Moving Higher for Oddity Tech (ODD): Time to Buy?
Oddity Tech: Turnaround Potential And Discounted Debt Value Lever
Why Oddity Tech's Stock Skyrocketed 26.5% Today
Already premium?